Astellas Pharma Inc.

OTC: ALPMY · Real-Time Price · USD
11.33
0.15 (1.34%)
At close: Aug 15, 2025, 3:58 PM
11.30
-0.26%
After-hours: Aug 15, 2025, 03:58 PM EDT

Astellas Pharma Cash Flow Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
31.24B 17.05B 98.71B 124.09B 120.59B
Depreciation & Amortization
199.13B 157.84B 105.74B 79.68B 72.65B
Stock-Based Compensation
n/a n/a n/a n/a n/a
Other Working Capital
-11.41B n/a 98.19B -16.64B 47.39B
Other Non-Cash Items
130.51B 84.11B 53.89B 65.07B 98.98B
Deferred Income Tax
n/a n/a n/a n/a n/a
Change in Working Capital
-166.37B -86.52B 73.98B -10.68B 15.66B
Operating Cash Flow
194.51B 172.47B 332.32B 258.16B 307.88B
Capital Expenditures
-57.33B -82.5B -88.54B -76.45B -77.44B
Cash Acquisitions
n/a -784.97B n/a -229M -8.09B
Purchase of Investments
n/a n/a n/a -5.58B n/a
Sales Maturities Of Investments
12.92B n/a 12.62B 5.58B n/a
Other Investing Acitivies
-65.34B -22.77B -13.14B 13.55B 2.6B
Investing Cash Flow
-89.42B -845.8B -89.06B -63.13B -82.93B
Debt Repayment
-88.52B 771.23B -15B -60B -126B
Common Stock Repurchased
-6.96B -10.73B -60.56B -50.72B -9.16B
Dividend Paid
-128.99B -116.65B -100.36B -85.24B -76.16B
Other Financial Acitivies
-36.89B -29.79B -19.71B -20.34B -18.16B
Financial Cash Flow
-261.37B 614.06B -195.62B -216.3B -229.48B
Net Cash Flow
-147.31B -41.15B 60.85B -10.14B 7.74B
Free Cash Flow
137.18B 89.98B 243.78B 181.71B 230.44B